# 30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers

> **NCT00587496** · PHASE1 · UNKNOWN · sponsor: **National Eye Institute (NEI)** · enrollment: 60 (estimated)

## Conditions studied

- Herpes Simplex

## Interventions

- **DRUG:** valacyclovir hydrochloride
- **DRUG:** placebo
- **DRUG:** valacyclovir plus aspirin

## Key facts

- **NCT ID:** NCT00587496
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-04
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2008-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00587496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00587496, "30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00587496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*